Results 101 to 110 of about 7,902 (150)

Sabr, Chwas

, 2017
Sabr, Chwas
core  

Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society. [PDF]

Explor Target Antitumor Ther
Kaidarova D, Omarova I, Kaldarbekov S, Omarbayeva N, Dzhugashvili M, Ulrikh E, Alisheva D, Bereketov B, Tsimafeyeu I, Mitin T.   +9 more
europepmc   +1 more source

Curative Oligometastatic Radiation Therapy: Why We Should Redefine Intent When Cure May Be Attainable. [PDF]

Adv Radiat Oncol
Wallach JB, Kelly MD, Shapiro R, McGunigal M, Lee SP, Hoffman-Hogg L, Wechsler G, Gutt R, Veterans Health Administration Palliative Radiotherapy Task Force.   +8 more
europepmc   +1 more source

Evaluation of postoperative stereotactic ablative radiotherapy <i>vs</i>. conventional fractionation in head and neck sarcomas. [PDF]

Rep Pract Oncol Radiother
Kahvecioglu A, Bay M, Cengiz M, Sari SY, Kuscu O, Gullu I, Yazici G.   +6 more
europepmc   +1 more source

Radiobiotherapy in Osteosarcoma: A State-Based Educational Framework for Strategy Selection and Trial Design. [PDF]

Curr Oncol
Vijayakumar S, Lewis S, Matrana M, Vasquez RJ, Singh A, Duesbery N, Collier AB, Larned Z, Barr J, Orr WR, Nittala MR, Vijayakumar V.   +11 more
europepmc   +1 more source

Complete response in disseminated <i>EGFR</i>-mutated lung adenocarcinoma through chemosensitivity-guided chemotherapy, osimertinib, and stereotactic ablative body radiotherapy: a case report. [PDF]

Transl Lung Cancer Res
Vukovac EL, Perić I, Batel A, Popović V, Marinović-Terzić I.   +4 more
europepmc   +1 more source

Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial. [PDF]

BMJ Open
Bedir A, Hassan L, Wittenberg I, Müller JA, Oesterling F, Walles T, Stang A, Vordermark D, Medenwald D.   +8 more
europepmc   +1 more source

Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer. [PDF]

Breast
De la Pinta C, Gamero V, Muriel A, Capuz AB, Moris R, Martin M, Alarza M, Montero A, Muñoz MT, Hernanz R, García Bermejo ML, Sancho S.   +11 more
europepmc   +1 more source

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma. [PDF]

Nat Commun
To V, Thio N, Castle R, Macdonald S, Molden-Hauer T, Wells J, McMahon R, Bressel M, Tran B, Azad AA, Moon D, Appu S, Wong LM, Murphy DG, Cuff K, Pryor D, Spain L, Au L, D'Souza C, Neeson PJ, Siva S.   +20 more
europepmc   +1 more source